Volume 18, Number 2—February 2012
Invasive Pneumococcal Disease and Pandemic (H1N1) 2009, Denver, Colorado, USA
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.
Release date: January 25, 2011; Expiration date: January 25, 2012
Upon completion of this activity, participants will be able to:
• Evaluate the epidemiology of pandemic (H1N1) 2009 in cases of invasive pneumococcal disease (IPD).
• Distinguish variables associated with IPD during the period of circulating pandemic (H1N1) 2009.
• Assess patterns of vaccination and antiviral treatment among patients with IPD.
• Analyze the severity of IPD during the period of circulating pandemic (H1N1) 2009.
Thomas J. Gryczan, MS, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Thomas J. Gryczan, MS, has disclosed no relevant financial relationships.
Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.
Disclosures: George E. Nelson, MD; Kenneth A. Gershman, MD, MPH; David L. Swerdlow, MD; Bernard W. Beall, PhD; and Matthew R. Moore, MD, MPH, have disclosed no relevant financial relationships.
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: January 26, 2012
- Page last updated: January 26, 2012
- Page last reviewed: January 26, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)